Roche Holding AG (ETR:RHO)
Germany
· Delayed Price · Currency is EUR 294.60
-5.40 (-1.80%)
At close: May 22, 2025
Revenue by Product
Fiscal year is January - December.
Year Ending | TTM | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
| Roche Pharmaceuticals | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Roche Pharmaceuticals Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Chugai | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Chugai Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals | 47.20B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Growth | 8.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics | 14.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Growth | 0.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capex by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
|---|---|---|---|---|---|
| Roche Pharmaceuticals Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Roche Pharmaceuticals Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Chugai Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Chugai Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
|---|---|---|---|---|---|
| Roche Pharmaceuticals Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Roche Pharmaceuticals Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Chugai Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Chugai Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
|---|---|---|---|---|---|
| Switzerland |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Switzerland Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of North America |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of North America Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Latin America |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Latin America Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Asia |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Asia Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Africa, Australia and Oceania |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Africa, Australia and Oceania Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|